Antares Pharma Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| LLY | Eli Lilly and | Outperform |
16
|
$745.95 | $636.99 | 12.27% | 9 | $671.93B |
| ABBV | AbbVie | Outperform |
9
|
$164.66 | $178.42 | 14.78% | 11 | $291.55B |
| PFE | Pfizer | Outperform |
2
|
$25.39 | $32.87 | 20.13% | 6 | $143.77B |
| BMY | Bristol-Myers Squibb | Hold |
2
|
$48.30 | $58.15 | 13.87% | 10 | $97.89B |
| CVS | CVS Health | Outperform |
12
|
$69.39 | $89.54 | 26.82% | 4 | $87.46B |
| GSK | GSK | Outperform |
12
|
£15.84 | £17.30 | 23.11% | 12 | £64.70B |
| SUNPHARMA | Sun Pharmaceutical Industries | Outperform |
8
|
Rp1.52k | Rp1.52k | 4.52% | 25 | Rp3.64T |
| WST | West Pharmaceutical Services | Outperform |
18
|
$377.33 | $380.80 | 0.71% | 2 | $27.62B |
| TEVA | Teva Pharmaceutical Industries | Outperform |
12
|
$12.78 | $11.59 | 25.20% | 9 | $14.48B |
| VTRS | Viatris Inc | Hold |
8
|
$11.12 | $11.73 | 7.91% | 5 | $13.21B |
| YPSN | Ypsomed Holding | Buy |
18
|
CHF380.00 | CHF330.00 | -3.95% | 1 | CHF4.98B |
| 4183 | Mitsui Chemicals | Outperform |
18
|
¥3.99k | ¥4.62k | 27.98% | 0 | ¥837.19B |
| PRGO | Perrigo Co PLC | Outperform |
16
|
$29.94 | $44.75 | 33.60% | 0 | $3.70B |
| ALCJ | Crossject Société Anonyme | Buy |
9
|
2.04€ | 7.10€ | 145.10% | 0 | 157.05€M |
| MDP | Medexus Pharmaceuticals | Outperform |
0
|
C$1.55 | C$4.08 | 93.55% | 1 | C$37.91M |